Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-25-035504
Filing Date
2025-04-16
Accepted
2025-04-16 16:10:37
Documents
15
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A tm2512321d1_10ka.htm   iXBRL 10-K/A 445134
2 EXHIBIT 31.1 tm2512321d1_ex31-1.htm EX-31.1 4143
3 EXHIBIT 31.2 tm2512321d1_ex31-2.htm EX-31.2 4141
  Complete submission text file 0001104659-25-035504.txt   737982

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cmrx-20241231.xsd EX-101.SCH 3072
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cmrx-20241231_lab.xml EX-101.LAB 36883
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cmrx-20241231_pre.xml EX-101.PRE 24145
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2512321d1_10ka_htm.xml XML 7647
Mailing Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713
Business Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713 919.806.1074
CHIMERIX INC (Filer) CIK: 0001117480 (see all company filings)

EIN.: 330903395 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-35867 | Film No.: 25842961
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)